Web Analytics

3 Latest Announced Rounds

  • $2,500,000
    Unknown

    1 Investors

    Services for Renewable Energy
    Nov 22nd, 2024
  • $3,700,000
    Pre-Series B

    1 Investors

    Financial Services
    Nov 22nd, 2024
  • $45,000,000
    Series C

    1 Investors

    Renewable Energy Semiconductor Manufacturing
    Nov 22nd, 2024
$2,202.93M Raised in 92 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Newcells Biotech Ltd

start up
United Kingdom - Newcastle upon Tyne
  • 15/02/2024
  • Unknown
  • $2,350,000

In vitro tissue models validated to mimic in vivo human physiology to improve confidence in drug discovery

We are experts in building and applying complex models of human tissues for drug discovery.
We are cell biologists, tissue physiologists and assay development scientists focused on building models that balance complexity, functionality, throughput and efficiency to improve the predictive power of in vitro data.

We carry out in vitro studies or provide products that enable customers to generate data on efficacy, safety and transport to de-risk discovery and development.

Our experts collaborate with customers to design studies to provide data that answer critical questions for pre-clinical drug development. We run the study, provide and interpret the data, or we can supply products and support you in your in-house studies.


Related People

Dr Mike NicholdsFounder

Dr Mike Nicholds United Kingdom - England

An experienced executive with extensive board and senior level achievement in biotechnology, electronics and chemical based B2B companies serving global customers in the pharmaceutical, biotechnology, agrochemical and electronic industries. Extensive experience in strategy development, business development and implementation in research and technology intensive businesses.

Specialties: - Strategy development and implementation
- Non-executive and executive board experience
- Fund raising
- Acquisition and licensing
- International business development
- Start-up and technology commercialisation